Katie R Mollan
Cited by
Cited by
Abacavir–lamivudine versus tenofovir–emtricitabine for initial HIV-1 therapy
PE Sax, C Tierney, AC Collier, MA Fischl, K Mollan, L Peeples, C Godfrey, ...
New England Journal of Medicine 361 (23), 2230-2240, 2009
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1: a randomized trial
ES Daar, C Tierney, MA Fischl, PE Sax, K Mollan, C Budhathoki, ...
Annals of internal medicine 154 (7), 445-456, 2011
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data
KR Mollan, M Smurzynski, JJ Eron, ES Daar, TB Campbell, PE Sax, ...
Annals of internal medicine 161 (1), 1-10, 2014
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
WA Fischer, JJ Eron Jr, W Holman, MS Cohen, L Fang, LJ Szewczyk, ...
Science translational medicine 14 (628), eabl7430, 2021
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results
PE Sax, C Tierney, AC Collier, ES Daar, K Mollan, C Budhathoki, ...
Journal of Infectious Diseases 204 (8), 1191-1201, 2011
Molnupiravir, an oral antiviral treatment for COVID-19
W Fischer, JJ Eron Jr, W Holman, MS Cohen, L Fang, LJ Szewczyk, ...
MedRxiv, 2021.06. 17.21258639, 2021
Crowdsourcing HIV test promotion videos: a noninferiority randomized controlled trial in China
W Tang, L Han, J Best, Y Zhang, K Mollan, J Kim, F Liu, M Hudgens, ...
Clinical infectious diseases 62 (11), 1436-1442, 2016
Crowdsourcing to expand HIV testing among men who have sex with men in China: a closed cohort stepped wedge cluster randomized controlled trial
W Tang, C Wei, B Cao, D Wu, KT Li, H Lu, W Ma, D Kang, H Li, M Liao, ...
PLoS medicine 15 (8), e1002645, 2018
Generalizing evidence from randomized trials using inverse probability of sampling weights
AL Buchanan, MG Hudgens, SR Cole, KR Mollan, PE Sax, ES Daar, ...
Journal of the Royal Statistical Society Series A: Statistics in Society 181 …, 2018
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and …
WC Miller, IF Hoffman, BS Hanscom, TV Ha, K Dumchev, Z Djoerban, ...
The Lancet 392 (10149), 747-759, 2018
The differential short-and long-term effects of HIV-1 latency-reversing agents on T cell function
G Clutton, Y Xu, PL Baldoni, KR Mollan, J Kirchherr, W Newhard, K Cox, ...
Scientific reports 6 (1), 30749, 2016
Ultra-long-acting removable drug delivery system for HIV treatment and prevention
M Kovarova, SR Benhabbour, I Massud, RA Spagnuolo, B Skinner, ...
Nature communications 9 (1), 4156, 2018
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes
TJ Wilkin, JE McKinnon, AG DiRienzo, K Mollan, CV Fletcher, ...
The Journal of infectious diseases 199 (6), 866-871, 2009
Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention
MR Nicol, Y Fedoriw, M Mathews, HMA Prince, KB Patterson, E Geller, ...
The Journal of Clinical Pharmacology 54 (5), 574-583, 2014
Incident HIV among pregnant and breastfeeding women in sub-Saharan Africa: a systematic review and meta-analysis
LA Graybill, M Kasaro, K Freeborn, JS Walker, C Poole, KA Powers, ...
AIDS (London, England) 34 (5), 761, 2020
Disclosure of sexual orientation to health professionals in China: results from an online cross‐sectional study
W Tang, J Mao, S Tang, C Liu, K Mollan, B Cao, T Wong, Y Zhang, ...
Journal of the International AIDS Society 20 (1), 21416, 2017
Benefits and potential harms of HIV self-testing among men who have sex with men in China: an implementation perspective
Y Qin, W Tang, A Nowacki, K Mollan, SA Reifeis, MG Hudgens, NS Wong, ...
Sexually transmitted diseases 44 (4), 233, 2017
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine
KY Smith, C Tierney, K Mollan, CS Venuto, C Budhathoki, Q Ma, ...
Clinical infectious diseases 58 (4), 555-563, 2014
The interplay between immune maturation, age, chronic viral infection and environment
KL Oxford, MGA dela Pena-Ponce, K Jensen, MK Eberhardt, A Spinner, ...
Immunity & Ageing 12, 1-20, 2015
Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfection
CB Jabara, F Hu, KR Mollan, SE Williford, P Menezes, Y Yang, JJ Eron, ...
Antimicrobial agents and chemotherapy 58 (10), 6079-6092, 2014
The system can't perform the operation now. Try again later.
Articles 1–20